Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Invested Capital (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Invested Capital for 16 consecutive years, with $61.7 million as the latest value for Q3 2025.

  • Quarterly Invested Capital rose 5.25% to $61.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $61.7 million through Sep 2025, up 5.25% year-over-year, with the annual reading at $65.0 million for FY2024, 16.13% up from the prior year.
  • Invested Capital for Q3 2025 was $61.7 million at Xtant Medical Holdings, up from $60.5 million in the prior quarter.
  • The five-year high for Invested Capital was $65.0 million in Q4 2024, with the low at $31.9 million in Q2 2022.
  • Average Invested Capital over 5 years is $47.3 million, with a median of $47.4 million recorded in 2023.
  • Peak annual rise in Invested Capital hit 181.01% in 2021, while the deepest fall reached 24.71% in 2021.
  • Over 5 years, Invested Capital stood at $34.5 million in 2021, then rose by 27.11% to $43.9 million in 2022, then increased by 27.62% to $56.0 million in 2023, then grew by 16.13% to $65.0 million in 2024, then dropped by 5.09% to $61.7 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $61.7 million, $60.5 million, and $55.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.